OR WAIT null SECS
Industry news focusing on the people and organizations who work in the clinical trials profession.
• With 20 years of experience within the IT industry, particularly for life sciences companies, Adam Sherlock will become Image Solution's (Whippany, NJ) managing director of Europe, after having served as the company's director of business development.
•Lex Jansen will serve as Octagon Research Solution's (Wayne, PA) senior consultant of clinical data strategies. Bringing with him nearly 20 years of experience in the pharmaceutical industry, he previously served as a senior director of clinical information systems at TAKE Solutions (Princeton, NJ).
•RadPharm (Princeton, NJ) appointed Steven Owens to the company's newly created position of chief information officer, where Owens will serve on the executive committee and provide leadership to IT and development projects.
•Vincent Renz has become the president of NewCardio (Santa Clara, CA), allotting him the responsibility of the company's business development, client services, software development, and quality assurance.
• Bringing with him 18 years of experience in a range of therapeutic areas, Warren Prosser, MBA, will serve as vice president of Clinical Operations for Global Neurology, with INC Research (Raleigh, NC).
•TOPIGEN Pharmaceuticals (Montreal, Quebec Canada) has appointed Mark Parry-Billings to chief executive officer, after serving as chief development officer since 2007.
•Serving as the company's president and chief operating officer since October 2007, the board of directors of Helicos BioSciences (Cambridge, MA) appointed Steve Lombardi as the new chief executive officer.
•Sepracor (Marlborough, MA) appointed two senior managers within the organization: Richard Ranieri fills the new position of executive vice president, human resources and administration; and Julio Casoy, MD, has been appointed to senior vice president of medical affairs.
•John Nestor has become the vice president of drug discovery for Transition Therapeutics (Toronto) where he will lead a group of research scientists in focusing on the company's new discovery projects.
•Scott Neilson joins AAIPharma (Wilmington, NC) as its new chief operating officer, which leaves him responsible for the company's global drug development services operations.
•After acting as BioDuro's vice president of business development and collaboration management, Steven Hutchins will become the new vice president of business development at Wuxi PharmaTech. The company also promoted Rujian Ma to vice president of synthetic chemistry.
•PhaseOneTrials has increased its staff with seven new members: Yasmina Sahraoui will become the senior director of business development; Karin Andersen is now the full time QA manager; Britt Bors Bonde, Birgit Hauggaard-Nielsen, and Hanne Sogaard will serve as study nurses; and Dorthe Baunbjerg Nielsen is the new coordinator of lab and logistics.
•Ikaria (Clinton, NJ) has added two new executive members to its team, including Stephen Ross as senior vice president of commercial operations, and James Briggs who will serve as senior vice president of human relations.
•Continuing on its ambitious goal of discovering as many drugs as possible within 18 months, Addrenex (Durham, NC) has added three new members to its team: Steven Butts, MBA, has become vice president of commercial operations; Gary Beam is the new senior director of scientific affairs; and Yuki Prescott will serve as clinical trials manager.